BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7605998)

  • 1. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations.
    Göker E; Waltham M; Kheradpour A; Trippett T; Mazumdar M; Elisseyeff Y; Schnieders B; Steinherz P; Tan C; Berman E
    Blood; 1995 Jul; 86(2):677-84. PubMed ID: 7605998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
    Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
    Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study.
    Levy AS; Sather HN; Steinherz PG; Sowers R; La M; Moscow JA; Gaynon PS; Uckun FM; Bertino JR; Gorlick R;
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):688-95. PubMed ID: 12972803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia, in vitro and in vivo.
    Matheson EC; Hogarth LA; Case MC; Irving JA; Hall AG
    Carcinogenesis; 2007 Jun; 28(6):1341-6. PubMed ID: 17148505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the gene for human dihydrofolate reductase: an unlikely cause of clinical relapse in pediatric leukemia after therapy with methotrexate.
    Spencer HT; Sorrentino BP; Pui CH; Chunduru SK; Sleep SE; Blakley RL
    Leukemia; 1996 Mar; 10(3):439-46. PubMed ID: 8642859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay.
    Rots MG; Pieters R; Kaspers GJ; van Zantwijk CH; Noordhuis P; Mauritz R; Veerman AJ; Jansen G; Peters GJ
    Blood; 1999 Feb; 93(3):1067-74. PubMed ID: 9920857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767 (-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemia.
    Kodidela S; Pradhan SC; Dubashi B; Basu D
    Eur J Clin Pharmacol; 2015 Nov; 71(11):1349-58. PubMed ID: 26335211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permissivity for methotrexate-induced DHFR gene amplification correlates with the metastatic potential of rat adenocarcinoma cells.
    Lücke-Huhle C
    Carcinogenesis; 1994 Apr; 15(4):695-700. PubMed ID: 8149482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A second target of benzamide riboside: dihydrofolate reductase.
    Roussel B; Johnson-Farley N; Kerrigan JE; Scotto KW; Banerjee D; Felczak K; Pankiewicz KW; Gounder M; Lin H; Abali EE; Bertino JR
    Cancer Biol Ther; 2012 Nov; 13(13):1290-8. PubMed ID: 22954684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer research: from folate antagonism to molecular targets.
    Bertino JR
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):577-82. PubMed ID: 19959110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of resistance to antifolates, a review.
    Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
    Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between polymorphisms of dihydrofolate reductase and gamma glutamyl hydrolase genes and toxicity of high dose methotrexate in children with acute lymphoblastic leukemia.
    Koomdee N; Hongeng S; Apibal S; Pakakasama S
    Asian Pac J Cancer Prev; 2012; 13(7):3461-4. PubMed ID: 22994778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrofolate-reductase and thymidylate-synthase in childhood acute lymphoblastic leukemia.
    Volm M; Sauerbrey A; Zintl F
    Anticancer Res; 1994; 14(3B):1377-81. PubMed ID: 8067709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplification.
    Saito H; Kishi K; Narita M; Furukawa T; Nagura E; Maekawa T; Abe T; Shibata A
    Leuk Res; 1992; 16(3):217-26. PubMed ID: 1560671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues.
    Miyachi H; Takemura Y; Kobayashi H; Ando K; Ando Y
    Jpn J Cancer Res; 1993 Jan; 84(1):9-12. PubMed ID: 8449831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.
    Morganti M; Coronnello M; Caciagli B; Biondi C; Quattrone A; Capaccioli S; Mazzei T; Mini E
    Anticancer Drugs; 2000 Apr; 11(4):285-94. PubMed ID: 10898545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance.
    Catts VS; Farnsworth ML; Haber M; Norris MD; Lutze-Mann LH; Lock RB
    Leukemia; 2001 Jun; 15(6):929-35. PubMed ID: 11417479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
    Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
    Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate.
    Hashimoto MW; Nikaido O; Kobayashi N; Chang CC; Trosko JE; Mori T
    Carcinogenesis; 1996 Mar; 17(3):389-94. PubMed ID: 8631121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
    Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
    Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.